These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10959686)

  • 1. Acquired von Willebrand syndrome: from pathophysiology to management.
    Veyradier A; Jenkins CS; Fressinaud E; Meyer D
    Thromb Haemost; 2000 Aug; 84(2):175-82. PubMed ID: 10959686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acquired von Willebrand syndrome].
    Franchini M
    Recenti Prog Med; 2006; 97(7-8):417-21; quiz 440. PubMed ID: 16913181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent acquisitions in acquired and congenital von Willebrand disorders.
    Franchini M; Lippi G
    Clin Chim Acta; 2007 Feb; 377(1-2):62-9. PubMed ID: 17140556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acquired von Willebrand disease].
    Matsuda J
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):532-4. PubMed ID: 9833563
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of von Willebrand disease.
    Cox Gill J
    Hematol Oncol Clin North Am; 2004 Dec; 18(6):1277-99, viii. PubMed ID: 15511616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired von Willebrand syndrome].
    Sucker C; Stockschläder M; Zotz RB; Scharf RE
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1581-5. PubMed ID: 15243910
    [No Abstract]   [Full Text] [Related]  

  • 10. Reassessment of the correlation between the von Willebrand Factor activity, the PFA-100, and the bleeding time in patients with von Willebrand disease.
    Nitu-Whalley IC; Lee CA; Hermans C
    Thromb Haemost; 2001 Aug; 86(2):715-6. PubMed ID: 11522030
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease.
    van Genderen PJ; Terpstra W; Michiels JJ; Kapteijn L; van Vliet HH
    Thromb Haemost; 1995 May; 73(5):891-2. PubMed ID: 7482422
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology.
    Eikenboom JC
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):365-79. PubMed ID: 11686105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Barthels M; Budde U
    Hamostaseologie; 2005 Nov; 25(4):367-75. PubMed ID: 16395486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of inherited von Willebrand disease.
    Mannucci PM; Federici AB
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):455-62. PubMed ID: 11686109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.